Valle William 4
4 · TriSalus Life Sciences, Inc. · Filed Jan 31, 2025
Insider Transaction Report
Form 4
Valle William
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-29+6,250→ 6,250 totalExercise: $4.89Exp: 2035-01-28→ Common Stock (6,250 underlying) - Award
Director Stock Option (right to buy)
2025-01-29+35,000→ 35,000 totalExercise: $4.89Exp: 2035-01-28→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]The shares subject to the option shall fully vest on the one-year anniversary of the grant date of January 29, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.